The aim of the present study was to investigate if plasma endostatin levels were elevated in patients admitted to intensive care with severe COVID-19 and to determine if endostatin levels correlate to pulmonary hypoxia, inflammation and short-term mortality in these patients. Here, COL18A1 is linked to COVID-19.